Cargando…

Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer

PURPOSE: We conducted a phase III randomized controlled trial (RCT) to investigate the efficacy of postsurgical adjuvant immunotherapy combined with chemotherapy. The immunotherapy targets were residual micrometastases and clones resistant to chemotherapy. PATIENTS AND METHODS: Between April 2007 an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimura, Hideki, Matsui, Yukiko, Ishikawa, Aki, Nakajima, Takahiro, Yoshino, Mitsuru, Sakairi, Yuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282697/ https://www.ncbi.nlm.nih.gov/pubmed/25262164 http://dx.doi.org/10.1007/s00262-014-1613-0

Ejemplares similares

Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer
por: Kimura, Hideki, et al.
Publicado: (2018)

Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report
por: Kimura, Hideki, et al.
Publicado: (2008)

Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
por: Nava, Sara, et al.
Publicado: (2021)

Validation of EBUS-TBNA-integrated nodal staging in potentially node-positive non-small cell lung cancer
por: Sakairi, Yuichi, et al.
Publicado: (2013)

The D-dimer level predicts the postoperative prognosis in patients with non-small cell lung cancer
por: Shiina, Yuki, et al.
Publicado: (2019)

Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy
por: Cazzetta, Valentina, et al.
Publicado: (2021)

A critical role for natural killer cells in dendritic cell-based anticancer immunotherapy
por: McLellan, Alexander D
Publicado: (2014)

Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
por: Du, Hansong, et al.
Publicado: (2020)

The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy
por: Peterson, Erin E., et al.
Publicado: (2021)

Is needle biopsy a risk factor of pleural recurrence after surgery for non-small cell lung cancer?
por: Toyoda, Takahide, et al.
Publicado: (2020)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis
por: Yuan, Xin, et al.
Publicado: (2021)

Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancer
por: Chen, Yulong, et al.
Publicado: (2020)

Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials
por: Wang, Yan, et al.
Publicado: (2017)

Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
por: Cao, Jing, et al.
Publicado: (2019)

Evaluation of cell surface reactive immuno-adjuvant in combination with immunogenic cell death inducing drug for in situ chemo-immunotherapy
por: Walters, Adam A., et al.
Publicado: (2020)

Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer
por: Yang, Xinyi, et al.
Publicado: (2022)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
por: Liu, Yan, et al.
Publicado: (2017)

Pathological diagnosis of pulmonary large cell neuroendocrine carcinoma by endobronchial ultrasound‐guided transbronchial needle aspiration
por: Inage, Terunaga, et al.
Publicado: (2017)

Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)
por: Sands, Jacob M, et al.
Publicado: (2021)

Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy
por: Zimmermann, Jennifer, et al.
Publicado: (2022)

Natural Killer Cell-Based Immunotherapy against Glioblastoma
por: Morimoto, Takayuki, et al.
Publicado: (2023)

Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer
por: Shi, Liangrong, et al.
Publicado: (2012)

Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy
por: SEYA, Tsukasa, et al.
Publicado: (2018)

Natural Killer Cells and Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2023)

Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies
por: Yang, Yang, et al.
Publicado: (2021)

Cytokine-induced killer cell/dendritic cell–cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer: A systematic review and meta-analysis
por: Wang, Xiang, et al.
Publicado: (2018)

A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma
por: Pan, Qiu-Zhong, et al.
Publicado: (2015)

Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection
por: Pan, Qiu-Zhong, et al.
Publicado: (2020)

Radiomics is feasible for prediction of spread through air spaces in patients with nonsmall cell lung cancer
por: Onozato, Yuki, et al.
Publicado: (2021)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Natural killer cell immunotherapy in glioblastoma
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2022)

Natural killer cells in tumor immunotherapy
por: Wang, Dongyao, et al.
Publicado: (2023)

Left superior segmentectomy for a patient with displaced anomalous apicoposterior branches of the pulmonary vein and bronchus: a case report
por: Matsumoto, Hiroki, et al.
Publicado: (2021)

Risk factors of postoperative recurrence of primary spontaneous pneumothorax
por: Fujiwara, Taiki, et al.
Publicado: (2020)

Prediction of Nodal Metastasis in Lung Cancer Using Deep Learning of Endobronchial Ultrasound Images
por: Ito, Yuki, et al.
Publicado: (2022)

Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer
por: Shindo, Yoshitaro, et al.
Publicado: (2014)

Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells
por: Gammaitoni, Loretta, et al.
Publicado: (2015)

Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy
por: Mathan, Till S.M., et al.
Publicado: (2017)

Clinical applications of dendritic cells–cytokine-induced killer cells mediated immunotherapy for pancreatic cancer: an up-to-date meta-analysis
por: Zhang, Yucai, et al.
Publicado: (2017)

FOLFOX regimen plus dendritic cells–cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis
por: Liu, Yan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_78b8u4himiq0fov899v0838sm8